Breastfeeding has clear short-term benefits for the baby 
HCMV reactivation during lactation
HCMV, a b-herpesvirus, persists following primary infection for lifetime in hematopoetic CD34+ precursor cells and may be reactivated by stress, transient loss of CD4+ and CD8+ T-cell immunity, IL-6 signalling, cell cycle arrest, and DNA damage 3 . Interestingly, HCMV is also reactivated in healthy immunocompetent seropositive women during lactation 4 . The ratio of HCMV reactivation at any stage of breastfeeding during the first three months after birth is very high (>95%) and nearly equals the maternal seroprevalence 5, 6 . The mechanisms leading to viral shedding exclusively into breastmilk are not understood. HCMV seroprevalences in Western Europe, USA, Canada, and Australia range from 40-60%, and are above 90% in South Africa, Brazil, India, Japan, and Turkey 7 .
Maternal HCMV reactivation of seropositive mothers during lactation with shedding of viral DNA and virolactia 8 can be detected already in colostrum and normally ends after about three months after birth. According to our experience with individual kinetics of HCMV reactivation in breastmilk of more than 500 healthy HIV-negative breastfeeding mothers of preterm infants, the onset of viral shedding begins with low viral load (<1000 copies/mL) and low infectivity (without detectable infected fibroblast nuclei in short-term microculture) at the end of the first week post partum (p.p.). The onset, the dynamics, and the end of virus shedding into milk is inter-individually different and describes mostly unimodal kinetics (Fig. 1) . The viral reactivation during lactation is a strictly self-limited process 8 . Using overnight microculture from cell-and fat-free milk whey, virolactia peaks coincide with viral DNA peak values, varying from 10 3 -10 6 copies HCMV DNA/mL of milk whey 9 .
The initiation of viral shedding into colostrum shows divergent results. While in Gambia HCMV excretion in colostrum and genital tract were observed in 100% of congenitally infected, and 48% of early infected infants 10 , a study from Japan showed, that in seven cases of very low birthweight (VLBW) infants the initial viral load in breastmilk in the first week p.p. ranges between 10 and <1000 copies/mL HCMV DNA 11 . In contrast, an Italian group detected viral DNA in 31 out of 57 (54%) colostrum samples 12 .
The HCMV reactivation of HIV-negative mothers during lactation is a local process without detection of a disseminated or compartmentalised infection in plasma, throat or cervical swabs [13] [14] [15] . Therefore, HCMV DNA, viral late pp67 transcripts and virions can only be detected in breastmilk cells and cell-free milk whey 8, 9, 16, 17 . Viral cells involved in HCMV reactivation include CD14+ macrophages 9 .
However, HCMV-infected milk cells are not essential for virus transmission 8, 15 . Several reports found an association between high HCMV viral load in breastmilk and risk of transmission 18, 19 .
However, other observations seem to be important in the context of prevention 11 . An inverse correlation between milk HCMV-specific
IgG avidity and HCMV load was also found 20 .
In HIV/HCMV coinfected breastfeeding mothers many of the findings in the HIV-negative population are altered. Shedding of HCMV and potentially Epstein-Barr virus (EBV) in breastmilk is associated with HIV-1 transmission by breastfeeding 21 . About 5% of HIV-1-positive breastfeeding mothers had detectable HCMV DNA perinatally in plasma. There was a strong correlation between cervical HCMV DNA detection during pregnancy and later breast milk HCMV levels. Maternal HCMV DNA breastmilk levels and CD4 <450 cells/mm 3 were determinants of HCMV transmission 22 . All HIV-1-infected inocula like genital secretions, breastmilk and blood contain cell-free virus and infected cells 23 .
Postnatal HCMV infection of very preterm infants: neonatal entity and prevention
Sepsis-like symptoms (SLS) have been introduced as a term to describe symptomatic postnatal HCMV disease in VLBW preterm infants, comprising apnea and bradycardia, hepatosplenomegaly, grey pallor and distending bowels 24, 25 . Following maternal HCMV reactivation and shedding into BM (in 96% of seropositive mothers), the incidence of HCMV transmission to the infant feeding raw, untreated breastmilk was 38% at the age of 3 months corrected age, 18% of the infants had one or more SLS 5 . Virological data could be almost exactly confirmed by a recent report 6 and clinical findings The onset of viral excretion was detected at day 6 post partum (p.p.) with 23 infected fibroblast nuclei/mL, and 12 000 copies HCMV DNA/mL milk whey. Co-culture of total milk cell fraction and fibroblasts stained positive from day 9. At day 6, nested PCR from 64 000 milk cells was negative for HCMV IE1-Ex4 DNA. After peak value of viral DNA and virolactia, milk cells were PCR-negative until day 90 p.p.
Under the Microscope components in milk like HCMV-specific antibodies and enzymes 38, 39 , while Holder pasteurisation does not. Using this method the benefits of BM feeding can be preserved without the disadvantages of CMV transmission.
Freeze-thawing at -208C for time intervals ranging from 18 h to 10 days is not efficient in viral elimination 38, 40, 41 . Extended duration of cryopreservation of native breast milk at -208C from 18 h to 60 days is not efficient for complete virus killing (see Table 1 ) during decrease of viral DNAlactia and virolactia from peak level to baseline viral shedding, as shown in Fig. 1 .
Long-term outcome
An earlier study revealed a significant association of postnatal HCMV infection in infants with birthweight <2000 g and neurologic sequelae and handicaps at 3 years of age 42 . In a more recent study, there was no difference in the neurodevelopmental outcome between VLBW infants with postnatal HCMV infection acquired during their stay in the neonatal intensive care unit and their matched controls at the age of 2-4 years 43 . However, this changed at the age of 4-10 years and 11-16 years: the cognitive outcome of the HCMV infected infants was significantly lower than their controls using K-ABC and HAWIK, the latter with a difference of 93 v. 103
(P < 0.03) [44] [45] [46] .
Summary
In conclusion, there is a relevant entity of postnatally acquired symptomatic CMV infection and disease of very preterm infants through raw breastmilk. Actual data are supporting negative influence on long-term cognitive development. Concerning prevention, only heat-inactivation is effective and short-term heat-inactivation preserves the nutritional and immunological capacity of breast milk 39 . Course of lactation of the HIV-negative mother of preterm twins from Fig. 1 . Duration of cryopreservation ranged from 18 h to 2 months at -208C. Freeze-thawing was performed with aliquots of the raw milk. The results from Fig. 1 correspond to the untreated control. Milk whey was prepared after the given cryostorage time. Using quantitative PCR (Cobas Roche Amplicor) no significant difference related to controls during cryopreservation can be detected. However, short-term 18 h microculture revealed the effect of reduction in infectivity. Residual viral infectivity after cryostorage is given in % of the untreated freshly expressed control milk. Efficiency strongly depends from stage of lactation (see Fig. 1 ).
